Clinical trial design issues in the era of targeted therapies

Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.

Original languageEnglish (US)
Pages (from-to)4281s-4282s
JournalClinical Cancer Research
Issue number12 II
StatePublished - Jul 15 2004

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Clinical trial design issues in the era of targeted therapies'. Together they form a unique fingerprint.

Cite this